Close Menu

HIV

NEW YORK (GenomeWeb News) – Researchers from Baylor College of Medicine have received a $3 million grant from the National Institutes of Health to collaborate with partners in Africa to study genetic factors involved in tuberculosis and HIV.

NEW YORK (GenomeWeb News) – The National Institutes of Health plans to fund researchers seeking to find out more about the pathogenic mechanisms, including genetic and epigenetic factors, that are involved in neurocognitive disorders caused by or associated with HIV infection.

NEW YORK (GenomeWeb News) – French molecular diagnostics firm Theradiag announced Monday that its microRNA diagnostics subsidiary Prestizia has inked two deals to develop HIV/AIDS assays in collaboration with the French National Center for Scientific Research (CNRS).

NEW YORK (GenomeWeb News) – Researchers at Emory University's Yerkes National Primate Research Center have received a $3.3 million grant from the National Institutes of Health to try to identify genes that are involved in HIV transmission and those that may help protect against HIV infection, Emo

NEW YORK (GenomeWeb News) – In Nature Genetics, researchers from University College London, the Wellcome Trust Sanger Institute, and elsewhere described mutations in a pair of histone-coding gen

The National Institutes of Health this week announced that it plans to issue a funding opportunity designed to foster research into new strategies for fighting HIV, including ones based on siRNAs and microRNAs.

A combination of pooled nucleic acid testing and social marketing improved early diagnosis of HIV infection in men who have sex with men in Vancouver, according to research published this week.

Tasso, a two-year-old startup focused on point-of-care, blood-based diagnostics, has been awarded a Phase I Small Business Innovation Research grant from the National Institutes of Health to develop a sample preparation and stabilization device for use with HIV viral load quantif

Researchers at the Gladstone Institutes and the University of California, San Francisco are evaluating next-generation sequencing for its ability to detect early signs of drug resistance in HIV patients.

Integrated Diagnostics said this week that it has spun out its protein catalyzed capture agent business into a new firm, InDi Molecular.

Pages

In PLOS this week: transcriptomic and genomic analysis of prostate cancer by ancestry, genes linked to liver function in Korean cohort, and more.

British Columbia is incorporating genomics into its tracking of the ongoing COVID-19 outbreak, Business in Vancouver reports.

An analysis by the Personalized Medicine Coalition finds that about a quarter of new drugs approved in 2019 by the US Food and Drug Administration were personalized medicines.

The governor of New York has proposed a five-year plan to study the genomes of people with or who are at high risk of developing Alzheimer's disease.